Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer

John Eklund, Mark Kozloff, Joy Vlamakis, Alexander Starr, Margaret Mariott, Lilia Gallot, Borko Jovanovic, Lawrence Schilder, Erwin Robin, Michael Pins, Raymond C. Bergan*

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

19 Scopus citations

Fingerprint Dive into the research topics of 'Phase II study of mitoxantrone and ketoconazole for hormone-refractory prostate cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences